Detalhe da pesquisa
1.
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Kidney Int
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697479
2.
Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials.
Am J Kidney Dis
; 83(2): 151-161, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726051
3.
Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
Am J Kidney Dis
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452919
4.
The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Kidney Int
; 104(6): 1194-1205, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652206
5.
Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19.
Am J Kidney Dis
; 82(3): 322-332.e1, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263570
6.
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Am J Kidney Dis
; 81(2): 190-200, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108888
7.
Derivation and independent validation of kidneyintelX.dkd: A prognostic test for the assessment of diabetic kidney disease progression.
Diabetes Obes Metab
; 25(12): 3779-3787, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722962
8.
Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis.
Blood Purif
; 52(2): 114-121, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599315
9.
Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes.
J Am Soc Nephrol
; 33(9): 1657-1672, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858701
10.
Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D.
J Am Soc Nephrol
; 33(5): 996-1010, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314457
11.
Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury.
J Am Soc Nephrol
; 33(3): 613-627, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017169
12.
Optimizing the Design and Analysis of Future AKI Trials.
J Am Soc Nephrol
; 33(8): 1459-1470, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831022
13.
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19.
Am J Kidney Dis
; 79(2): 257-267.e1, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710516
14.
Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
Am J Kidney Dis
; 79(6): 849-857.e1, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752914
15.
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.
Cardiovasc Diabetol
; 21(1): 194, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151557
16.
Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-19.
Am J Nephrol
; 53(1): 78-86, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883482
17.
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
Am J Nephrol
; 53(1): 50-58, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034024
18.
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial.
Am J Nephrol
; 53(1): 21-31, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016188
19.
Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes.
Am J Nephrol
; 53(11-12): 775-785, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630924
20.
Role of time from transplantation to biopsy in histologic ABMR: A single center report.
Clin Transplant
; 36(12): e14802, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069577